Depomed, founded in 1995 by John W. Shell, is a specialty pharmaceutical company engaged in the development of pharmaceutical products based on its proprietary oral drug delivery technologies. The AcuForm gastric retentive delivery system can provide controlled and prolonged release of drugs. Depomed is developing its own proprietary products as well as the products of its partners utilizing its AcuForm technology. The company has multiple collaborations with worldwide pharmaceutical companies. T